Authors:
SEINO K
IWABUCHI K
KAYAGAKI N
MIYATA R
NAGAOKA I
MATSUZAWA A
FUKAO K
YAGITA H
OKUMURA K
Citation: K. Seino et al., CUTTING EDGE - CHEMOTACTIC ACTIVITY OF SOLUBLE FAS LIGAND AGAINST PHAGOCYTES, The Journal of immunology (1950), 161(9), 1998, pp. 4484-4488
Authors:
TAKEDA Y
GOTOH M
DONO K
NISHIHARA M
GROCHOWIECKI T
KIMURA F
YOSHIDA T
OHTA Y
OTA H
OHZATO H
UMESHITA K
TAKEDA T
MATSUURA N
SAKON M
KAYAGAKI N
YAGITA H
OKUMURA K
MIYASAKA M
MONDEN M
Citation: Y. Takeda et al., PROTECTION OF ISLET ALLOGRAFTS TRANSPLANTED TOGETHER WITH FAS LIGAND EXPRESSING TESTICULAR ALLOGRAFTS, Diabetologia, 41(3), 1998, pp. 315-321
Authors:
JODO S
KOBAYASHI S
NAKAJIMA Y
MATSUNAGA T
NAKAYAMA N
OGURA N
KAYAGAKI N
OKUMURA K
KOIKE T
Citation: S. Jodo et al., ELEVATED SERUM LEVELS OF SOLUBLE FAS APO-1 (CD95) IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA/, Clinical and experimental immunology, 112(2), 1998, pp. 166-171
Authors:
HATTORI K
HIRANO T
MIYAJIMA H
YAMAKAWA N
TATENO M
OSHIMI K
KAYAGAKI N
YAGITA H
OKUMURA K
Citation: K. Hattori et al., DIFFERENTIAL-EFFECTS OF ANTI-FAS LIGAND AND ANTITUMOR NECROSIS FACTOR-ALPHA ANTIBODIES ON ACUTE GRAFT-VERSUS-HOST DISEASE PATHOLOGIES, Blood, 91(11), 1998, pp. 4051-4055
Authors:
NOZAWA K
KAYAGAKI N
TOKANO Y
YAGITA H
OKUMURA K
HASHIMOTO H
Citation: K. Nozawa et al., NO INCREASE IN SOLUBLE FAS AND FAS LIGAND IN KAWASAKI-DISEASE - COMMENT ON THE ARTICLE BY NOZAWA ET-AL - REPLY, Arthritis and rheumatism, 41(3), 1998, pp. 570-570
Authors:
NAKAJIMA M
NAKAJIMA A
KAYAGAKI N
HONDA M
YAGITA H
OKUMURA K
Citation: M. Nakajima et al., EXPRESSION OF FAS LIGAND AND ITS RECEPTOR IN CUTANEOUS LUPUS - IMPLICATION IN TISSUE-INJURY, Clinical immunology and immunopathology, 83(3), 1997, pp. 223-229
Authors:
YAMAGAMI S
KAWASHIMA H
TSURU T
YAMAGAMI H
KAYAGAKI N
YAGITA H
OKUMURA K
GREGERSON DS
Citation: S. Yamagami et al., ROLE OF FAS-FAS LIGAND INTERACTIONS IN THE IMMUNOREJECTION OF ALLOGENEIC MOUSE CORNEAL TRANSPLANTS, Transplantation, 64(8), 1997, pp. 1107-1111
Authors:
SEINO K
KAYAGAKI N
TSUKADA N
FUKAO K
YAGITA H
OKUMURA K
Citation: K. Seino et al., TRANSPLANTATION OF CD95 LIGAND-EXPRESSING GRAFTS - INFLUENCE OF TRANSPLANTATION SITE AND DIFFICULTY IN PROTECTING ALLOGRAFTS AND XENOGRAFTS, Transplantation, 64(7), 1997, pp. 1050-1054
Authors:
KAYAGAKI N
YAMAGUCHI N
NAGAO F
MATSUO S
MAEDA H
OKUMURA K
YAGITA H
Citation: N. Kayagaki et al., POLYMORPHISM OF MURINE FAS LIGAND THAT AFFECTS THE BIOLOGICAL-ACTIVITY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(8), 1997, pp. 3914-3919
Authors:
KONDO E
YOSHINO T
NISHIUCHI R
SAKUMA I
NISHIZAKI K
KAYAGAKI N
YAGITA H
AKAGI T
Citation: E. Kondo et al., EXPRESSION OF FAS LIGAND MESSENGER-RNA IN GERMINAL-CENTERS OF THE HUMAN TONSIL, Journal of pathology, 183(1), 1997, pp. 75-79
Authors:
OYAIZU N
ADACHI Y
HASHIMOTO F
MCCLOSKEY TW
HOSAKA N
KAYAGAKI N
YAGITA H
PAHWA S
Citation: N. Oyaizu et al., MONOCYTES EXPRESS FAS LIGAND UPON CD4 CROSS-LINKING AND INDUCE CD4(-CELLS APOPTOSIS - A POSSIBLE MECHANISM OF BYSTANDER CELL-DEATH IN HIV-INFECTION() T), The Journal of immunology, 158(5), 1997, pp. 2456-2463
Authors:
ANDO K
HIROISHI K
KANEKO T
MORIYAMA T
MUTO Y
KAYAGAKI N
YAGITA H
OKUMURA K
IMAWARI M
Citation: K. Ando et al., PERFORIN, FAS FAS LIGAND, AND TNF-ALPHA PATHWAYS AS SPECIFIC AND BYSTANDER KILLING MECHANISMS OF HEPATITIS-C VIRUS-SPECIFIC HUMAN CTL/, The Journal of immunology, 158(11), 1997, pp. 5283-5291
Authors:
KOBATA T
TAKASAKI K
ASAHARA H
HONG NM
MASUKOHONGO K
KATO T
HIROSE S
SHIRAI T
KAYAGAKI N
YAGITA H
OKUMURA K
NISHIOKA K
Citation: T. Kobata et al., APOPTOSIS WITH FASL(+) CELL INFILTRATION IN THE PERIPHERY AND THYMUS OF CORRECTED AUTOIMMUNE MICE, Immunology, 92(2), 1997, pp. 206-213
Authors:
WATANABE N
ARASE H
KURASAWA K
IWAMOTO I
KAYAGAKI N
YAGITA H
OKUMURA K
MIYATAKE S
SAITO T
Citation: N. Watanabe et al., TH1 AND TH2 SUBSETS EQUALLY UNDERGO FAS-DEPENDENT AND FAS-INDEPENDENTACTIVATION-INDUCED CELL-DEATH, European Journal of Immunology, 27(8), 1997, pp. 1858-1864
Authors:
JODO S
KOBAYASHI S
KAYAGAKI N
OGURA N
FENG Y
AMASAKI Y
FUJISAKU A
AZUMA M
YAGITA H
OKUMURA K
KOIKE T
Citation: S. Jodo et al., SERUM LEVELS OF SOLUBLE FAS APO-1 (CD95) AND ITS MOLECULAR-STRUCTURE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND OTHER AUTOIMMUNE-DISEASES/, Clinical and experimental immunology, 107(1), 1997, pp. 89-95
Authors:
HATTORI K
HIRANO T
TATENO M
OSHIMI K
KAYAGAKI N
YAGITA H
OKUMURA K
Citation: K. Hattori et al., THE SYNERGISTIC EFFECTS OF ANTI-FAS LIGAND AND TNF-ALPHA ANTIBODY ON THE PREVENTION OF LETHAL ACUTE GRAFT-VERSUS-HOST DISEASE IN MICE, Blood, 90(10), 1997, pp. 907-907
Authors:
OYAIZU N
KAYAGAKI N
YAGITA H
PAHWA S
IKAWA Y
Citation: N. Oyaizu et al., REQUIREMENT OF CELL-CELL CONTACT IN THE INDUCTION OF JURKAT T-CELL APOPTOSIS - THE MEMBRANE-ANCHORED BUT NOT SOLUBLE FORM OF FASL CAN TRIGGER ANTI-CD3-INDUCED APOPTOSIS IN JURKAT T-CELLS, Biochemical and biophysical research communications, 238(2), 1997, pp. 670-675
Authors:
NOZAWA K
KAYAGAKI N
TOKANO Y
YAGITA H
OKUMURA K
HASIMOTO H
Citation: K. Nozawa et al., SOLUBLE FAS (APO-1, CD95) AND SOLUBLE FAS LIGAND IN RHEUMATIC DISEASES, Arthritis and rheumatism, 40(6), 1997, pp. 1126-1129
Authors:
HASUNUMA T
KAYAGAKI N
ASAHARA H
MOTOKAWA S
KOBATA T
YAGITA H
AONO H
SUMIDA T
OKUMURA K
NISHIOKA K
Citation: T. Hasunuma et al., ACCUMULATION OF SOLUBLE FAS IN INFLAMED JOINTS OF PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 40(1), 1997, pp. 80-86